DHRHealth Institute for Research and Development
News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

A Phase II, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo In Patient With Non-Alcoholic Steatohepatitis

Study Status:

Open For Enrollment

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

This study will evaluate the efficacy, safety, and pharmacokinetics of BFKB8488A compared with placebo in patients with non-alcoholic steatohepatitis (NASH).


Principal Investigator
Fernando Membreno, MD
Genentech, Inc.
Type of Trial
© 2023 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram